Researchers are excited about the medication , a groundbreaking dual agonist showing significant outcomes in clinical trials for body reduction . It acts by impacting two hormones : GLP-1 and GIP, which https://lexieamts506250.thenerdsblog.com/46861908/the-new-prospect-for-size-loss